These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 26038698)

  • 1. Analysis of differential secondary effects of novel rexinoids: select rexinoid X receptor ligands demonstrate differentiated side effect profiles.
    Marshall PA; Jurutka PW; Wagner CE; van der Vaart A; Kaneko I; Chavez PI; Ma N; Bhogal JS; Shahani P; Swierski JC; MacNeill M
    Pharmacol Res Perspect; 2015 Mar; 3(2):e00122. PubMed ID: 26038698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methods to Assess Activity and Potency of Rexinoids Using Rapid Luciferase-Based Assays: A Case Study with NEt-TMN.
    Jurutka PW; Wagner CE
    Methods Mol Biol; 2019; 2019():95-108. PubMed ID: 31359391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing Novel Pyrimidinyl Rexinoids: A New Paradigm for Evaluating Rexinoids for Cancer Prevention.
    Zhang D; Leal AS; Carapellucci S; Shahani PH; Bhogal JS; Ibrahim S; Raban S; Jurutka PW; Marshall PA; Sporn MB; Wagner CE; Liby KT
    Cancer Prev Res (Phila); 2019 Apr; 12(4):211-224. PubMed ID: 30760500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel gene expression analytics-based approach to structure aided design of rexinoids for development as next-generation cancer therapeutics.
    Hanish BJ; Hackney Price JF; Kaneko I; Ma N; van der Vaart A; Wagner CE; Jurutka PW; Marshall PA
    Steroids; 2018 Jul; 135():36-49. PubMed ID: 29704526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rexinoids isolated from Sophora tonkinensis with a gene expression profile distinct from the synthetic rexinoid bexarotene.
    Inoue M; Tanabe H; Nakashima K; Ishida Y; Kotani H
    J Nat Prod; 2014 Jul; 77(7):1670-7. PubMed ID: 24959987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating Novel RXR Agonists That Induce ApoE and Tyrosine Hydroxylase in Cultured Human Glioblastoma Cells.
    Mallick S; Marshall PA; Wagner CE; Heck MC; Sabir ZL; Sabir MS; Dussik CM; Grozic A; Kaneko I; Jurutka PW
    ACS Chem Neurosci; 2021 Mar; 12(5):857-871. PubMed ID: 33570383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of rexinoids on thyrotrope function and the hypothalamic-pituitary-thyroid axis.
    Sharma V; Hays WR; Wood WM; Pugazhenthi U; St Germain DL; Bianco AC; Krezel W; Chambon P; Haugen BR
    Endocrinology; 2006 Mar; 147(3):1438-51. PubMed ID: 16306084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rexinoids Induce Differential Gene Expression in Human Glioblastoma Cells and Protein-Protein Interactions in a Yeast Two-Hybrid System.
    Hackney JF; Broatch JE; Dallal RA; Brotherson C; Livingston S; Sabir Z; Reshi SM; Faltermeier Petras SR; Mallick S; Applegate MT; Mellor NJ; Buss K; Blain JM; Wagner CE; Jurutka PW; Marshall PA
    ACS Chem Neurosci; 2024 Aug; 15(15):2897-2915. PubMed ID: 39012782
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformationally Defined Rexinoids for the Prevention of Inflammation and Nonmelanoma Skin Cancers.
    Atigadda VR; Kashyap MP; Yang Z; Chattopadhyay D; Melo N; Sinha R; Belyaeva OV; Chou CF; Chang PL; Kedishvili NY; Grubbs CJ; Renfrow MB; Muccio DD; Elmets CA; Athar M
    J Med Chem; 2022 Nov; 65(21):14409-14423. PubMed ID: 36318154
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation of RXR function through ligand design.
    Pérez E; Bourguet W; Gronemeyer H; de Lera AR
    Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 3H-Imidazo[4,5-b]pyridine-6-carboxylic acid derivatives as rexinoids with reduced teratogenicity.
    Takamura Y; Takahashi M; Nishii M; Shibahara O; Watanabe M; Fujihara M; Kakuta H
    Bioorg Med Chem Lett; 2019 Aug; 29(15):1891-1894. PubMed ID: 31160175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Single-dose rexinoid rapidly and specifically suppresses serum thyrotropin in normal subjects.
    Golden WM; Weber KB; Hernandez TL; Sherman SI; Woodmansee WW; Haugen BR
    J Clin Endocrinol Metab; 2007 Jan; 92(1):124-30. PubMed ID: 17062760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Advances in drug design with RXR modulators.
    Vaz B; de Lera ÁR
    Expert Opin Drug Discov; 2012 Nov; 7(11):1003-16. PubMed ID: 22954251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary specific retinoid-X receptor ligand interactions with thyroid hormone receptor signaling revealed by high throughput reporter and endogenous gene responses.
    Mengeling BJ; Furlow JD
    Toxicol In Vitro; 2015 Oct; 29(7):1609-18. PubMed ID: 26096596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
    Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
    Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rexinoid-triggered differentiation and tumor-selective apoptosis of acute myeloid leukemia by protein kinase A-mediated desubordination of retinoid X receptor.
    Altucci L; Rossin A; Hirsch O; Nebbioso A; Vitoux D; Wilhelm E; Guidez F; De Simone M; Schiavone EM; Grimwade D; Zelent A; de Thé H; Gronemeyer H
    Cancer Res; 2005 Oct; 65(19):8754-65. PubMed ID: 16204045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary Cancers.
    Atigadda VR; Xia G; Deshpande A; Wu L; Kedishvili N; Smith CD; Krontiras H; Bland KI; Grubbs CJ; Brouillette WJ; Muccio DD
    J Med Chem; 2015 Oct; 58(19):7763-74. PubMed ID: 26331194
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous rexinoid death signaling is suppressed by converging signaling pathways in immature leukemia cells.
    Benoit GR; Flexor M; Besançon F; Altucci L; Rossin A; Hillion J; Balajthy Z; Legres L; Ségal-Bendirdjian E; Gronemeyer H; Lanotte M
    Mol Endocrinol; 2001 Jul; 15(7):1154-69. PubMed ID: 11435615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging role of rexinoids in non-small cell lung cancer: focus on bexarotene.
    Rigas JR; Dragnev KH
    Oncologist; 2005 Jan; 10(1):22-33. PubMed ID: 15632250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic potential of retinoid x receptor modulators for the treatment of the metabolic syndrome.
    Pinaire JA; Reifel-Miller A
    PPAR Res; 2007; 2007():94156. PubMed ID: 17497022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.